SALT LAKE CITY (AP) _ Recursion Pharmaceuticals Inc. (RXRX) on Friday reported a loss of $43.4 million in its second quarter.

On a per-share basis, the Salt Lake City-based company said it had a loss of 31 cents.

The biotechnology company posted revenue of $2.5 million in the period, which fell short of Street forecasts. Three analysts surveyed by Zacks expected $2.7 million.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RXRX at https://www.zacks.com/ap/RXRX

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News